Document is current
Any future updates will be listed below
-
Authors
Iki, Masayuki https://orcid.org/0000-0003-2128-5255
Fujimori, Kenji
Okimoto, Nobukazu
Nakatoh, Shinichi
Tamaki, Junko
Ishii, Shigeyuki
Imano, Hironori
Ogawa, Sumito
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 29 November 2024
First Online: 10 December 2024
Declarations
:
: Nobukazu Okimoto has received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd. and Teijin Pharma Ltd., and payments for lectures, including speakers’ bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd., Amgen K.K., Daiichi-Sankyo Co., Ltd., and Teijin Pharma Ltd. Shinichi Nakatoh has received payments for lectures, including speakers’ bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd., Amgen K.K., and Daiichi-Sankyo Co., Ltd. Shigeyuki Ishii has received honorarium from Teijin Pharma Ltd., and has written manuscripts for Teijin Pharma Ltd. Masayuki Iki, Kenji Fujimori, Junko Tamaki, Hironori Imano, and Sumito Ogawa declare that they have no conflict of interest.
